Of course, both T1D and GDM pregnant women received appropriate treatment to achieve a good glycemic control (30), and this treatment may have influenced the expression and phosphorylation of IR and IGF-1R in the placenta at term, thus obscuring the differences. The gene discussed is IGF1R; the disease is gestational diabetes.